Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Effectiveness and Safety of Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
Sponsor: Galderma R&D
This NA trial investigates Midface Volume Deficit and is currently completed. Galderma R&D leads this study, which shows 10 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
10 versions recorded-
Feb 2025 — Present [monthly]
Completed NA
-
Jan 2025 — Feb 2025 [monthly]
Completed NA
Status: Unknown → Completed
-
Sep 2024 — Jan 2025 [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 5 earlier versions
-
Nov 2022 — Oct 2023 [monthly]
Active Not Recruiting NA
-
Oct 2021 — Nov 2022 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Dec 2019 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Galderma R&D
For direct contact, visit the study record on ClinicalTrials.gov .